AG1478 HCl
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 563014

CAS#: 170449-18-0

Description: Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTK. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors which preferentially inhibit the epidermal growth factor receptor (EGFR) kinase and block EGFR-dependent cell proliferation. AG-1478 is an inhibitor of EGFR kinase with an IC50 value of 3 nM.1 Due to its potency and selectivity, AG-1478 has been used in a broad range of studies. It reversibly inhibits rat brain Kv1.5 potassium channels (IC50 = 9.8 µM) independent of protein tyrosine kinase (PTK) activity.2 AG-1478 also inhibits the growth of leiomyoma and myometrium cell cultures with IC50 values of 5.6 and 5.7 µM, respectively. This inhibitor suppresses MAP kinase activation and strongly inhibits induction of fos gene expression and DNA synthesis.


Chemical Structure

img
AG1478 HCl
CAS# 170449-18-0

Theoretical Analysis

MedKoo Cat#: 563014
Name: AG1478 HCl
CAS#: 170449-18-0
Chemical Formula: C16H15Cl2N3O2
Exact Mass: 0.00
Molecular Weight: 352.210
Elemental Analysis: C, 54.56; H, 4.29; Cl, 20.13; N, 11.93; O, 9.08

Price and Availability

Size Price Availability Quantity
10mg USD 450 2 Weeks
50mg USD 1350 2 Weeks
Bulk inquiry

Synonym: AG1478 HCl; AG-1478 HCl; AG 1478 HCl; AG1478 Hydrochloride; AG 1478 Hydrochloride; AG-1478 Hydrochloride; Tyrphostin;

IUPAC/Chemical Name: N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride

InChi Key: WDJDYIUSDDVWKB-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H14ClN3O2.ClH/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11;/h3-9H,1-2H3,(H,18,19,20);1H

SMILES Code: COC1=CC2=NC=NC(NC3=CC=CC(Cl)=C3)=C2C=C1OC.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: AG-1478 hydrochloride (Tyrphostin AG-1478 hydrochloride) is a selective EGFR tyrosine kinase inhibitor with IC50 of 3 nM.
In vitro activity: To this end, HeLa cells were infected with either EMCV or CVB3 for 30 min, after which virus-containing medium was replaced with compound-containing medium. Eight hours later, cells were lysed by freeze-thawing to determine the total virus titers by endpoint dilution. As we have previously shown, AG1478 did not perturb CVB3 replication (Fig. 1B). However, EMCV was inhibited by AG1478 in a dose-dependent manner, with a complete inhibition at 25 μM. The inhibition observed with AG1478 was comparable to that obtained with 10 μM AL-9 (Fig. 1B). In parallel, a cell viability assay was performed to verify that the antiviral activity of AG1478 was not due to cytotoxic effects (Fig. 1B). Reference: Antimicrob Agents Chemother. 2016 Oct; 60(10): 6402–6406. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038282/
In vivo activity: As expected, CD31 was markedly increased in retinas of DM mice compared with the non-diabetic group (Figure 5A). In addition, the number of retinal vessels was significantly increased in the DM group (Figure 5C). However, treatment with AG1478 markedly reduced the number of CD31-positive cells and vessel density in retinas of DM mice (Figure 5A,C, respectively), supporting an anti-angiogenic effect of AG1478. Reference: Clin Exp Pharmacol Physiol. 2019 Jan;46(1):75-85. https://pubmed.ncbi.nlm.nih.gov/30221384/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 3.5 9.99

Preparing Stock Solutions

The following data is based on the product molecular weight 352.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Dorobantu CM, Harak C, Klein R, van der Linden L, Strating JR, van der Schaar HM, Lohmann V, van Kuppeveld FJ. Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6402-6. doi: 10.1128/AAC.01331-16. PMID: 27480860; PMCID: PMC5038282. 2. Ma L, Yan H, Zhou Q. AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9. Oncol Lett. 2014 Aug;8(2):921-927. doi: 10.3892/ol.2014.2224. Epub 2014 Jun 4. PMID: 25009665; PMCID: PMC4081427. 3. Ju X, Yang X, Yan T, Chen H, Song Z, Zhang Z, Wu W, Wang Y. EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy. Clin Exp Pharmacol Physiol. 2019 Jan;46(1):75-85. doi: 10.1111/1440-1681.13029. Epub 2018 Sep 16. PMID: 30221384. 4. Shimizu S, Takezawa-Yasuoka K, Ogawa T, Tojima I, Kouzaki H, Shimizu T. The epidermal growth factor receptor inhibitor AG1478 inhibits eosinophilic inflammation in upper airways. Clin Immunol. 2018 Mar;188:1-6. doi: 10.1016/j.clim.2017.11.010. Epub 2017 Nov 26. PMID: 29183867.
In vitro protocol: 1. Dorobantu CM, Harak C, Klein R, van der Linden L, Strating JR, van der Schaar HM, Lohmann V, van Kuppeveld FJ. Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6402-6. doi: 10.1128/AAC.01331-16. PMID: 27480860; PMCID: PMC5038282. 2. Ma L, Yan H, Zhou Q. AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9. Oncol Lett. 2014 Aug;8(2):921-927. doi: 10.3892/ol.2014.2224. Epub 2014 Jun 4. PMID: 25009665; PMCID: PMC4081427.
In vivo protocol: 1. Ju X, Yang X, Yan T, Chen H, Song Z, Zhang Z, Wu W, Wang Y. EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy. Clin Exp Pharmacol Physiol. 2019 Jan;46(1):75-85. doi: 10.1111/1440-1681.13029. Epub 2018 Sep 16. PMID: 30221384. 2. Shimizu S, Takezawa-Yasuoka K, Ogawa T, Tojima I, Kouzaki H, Shimizu T. The epidermal growth factor receptor inhibitor AG1478 inhibits eosinophilic inflammation in upper airways. Clin Immunol. 2018 Mar;188:1-6. doi: 10.1016/j.clim.2017.11.010. Epub 2017 Nov 26. PMID: 29183867.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Han Y, Caday CG, Nanda A, Cavenee WK, Huang HJ. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors. Cancer Res. 1996 Sep 1;56(17):3859-61. PMID: 8752145.


2: Khattab M, Wang F, Clayton AH. UV-Vis spectroscopy and solvatochromism of the tyrosine kinase inhibitor AG-1478. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jul 5;164:128-32. doi: 10.1016/j.saa.2016.04.009. Epub 2016 Apr 12. PMID: 27092736.


3: Choi BH, Choi JS, Rhie DJ, Yoon SH, Min DS, Jo YH, Kim MS, Hahn SJ. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor. Am J Physiol Cell Physiol. 2002 Jun;282(6):C1461-8. doi: 10.1152/ajpcell.00398.2001. PMID: 11997261.


4: Weglicki WB, Kramer JH, Spurney CF, Chmielinska JJ, Mak IT. The EGFR tyrosine kinase inhibitor tyrphostin AG-1478 causes hypomagnesemia and cardiac dysfunction. Can J Physiol Pharmacol. 2012 Aug;90(8):1145-9. doi: 10.1139/y2012-023. Epub 2012 May 30. PMID: 22646904; PMCID: PMC3734545.


5: Stekelenburg J, Klein BY, Ben-Bassat H, Rojansky N. Opposing effects of cyclosporin A and tyrphostin AG-1478 indicate a role for Src protein in the cellular control of mineralization. J Cell Biochem. 1998 Oct 1;71(1):116-26. doi: 10.1002/(sici)1097-4644(19981001)71:1<116::aid-jcb12>3.0.co;2-l. PMID: 9736460.


6: Clayton AH, Perugini MA, Weinstock J, Rothacker J, Watson KG, Burgess AW, Nice EC. Fluorescence and analytical ultracentrifugation analyses of the interaction of the tyrosine kinase inhibitor, tyrphostin AG 1478-mesylate, with albumin. Anal Biochem. 2005 Jul 15;342(2):292-9. doi: 10.1016/j.ab.2005.04.002. PMID: 15913535.


7: Hegab AE, Sakamoto T, Nomura A, Ishii Y, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Homma S, Sekizawa K. Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest. 2007 Apr;131(4):1149-56. doi: 10.1378/chest.06-2031. PMID: 17426222.


8: Osherov N, Levitzki A. Tyrphostin AG 494 blocks Cdk2 activation. FEBS Lett. 1997 Jun 30;410(2-3):187-90. doi: 10.1016/s0014-5793(97)00580-2. PMID: 9237626.


9: Klein BY, Tepper SH, Gal I, Shlomai Z, Ben-Bassat H. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells. J Cell Biochem. 1997 Jun 1;65(3):420-9. PMID: 9138097.


10: Li F, Zhou Y, Cheng N, Mao H, Jiang L, Li N, Li Q, de Jong MC, Pawlik TM. Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis. J Surg Res. 2011 Mar;166(1):87-94. doi: 10.1016/j.jss.2009.09.058. Epub 2009 Nov 11. PMID: 20097367.


11: Miyakawa M, Konno T, Kohno T, Kikuchi S, Tanaka H, Kojima T. Increase in Epithelial Permeability and Cell Metabolism by High Mobility Group Box 1, Inflammatory Cytokines and TPEN in Caco-2 Cells as a Novel Model of Inflammatory Bowel Disease. Int J Mol Sci. 2020 Nov 10;21(22):8434. doi: 10.3390/ijms21228434. PMID: 33182652; PMCID: PMC7696423.


12: Yu JL, Xing R, Milsom C, Rak J. Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1. Thromb Res. 2010 Jul;126(1):e6-10. doi: 10.1016/j.thromres.2010.04.014. PMID: 20553947.


13: You M, Xia X, Li H, Wu J, Rong R, Zeng Z, Xiong K, Huang J, Tang L, Lei H, Wu W, Ji D. Normal vitreous promotes angiogenesi via the epidermal growth factor receptor. FASEB J. 2020 Nov;34(11):14799-14809. doi: 10.1096/fj.201902862RRR. Epub 2020 Sep 10. PMID: 32910506.


14: Nagane M, Lin H, Cavenee WK, Huang HJ. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett. 2001 Jan;162 Suppl:S17-S21. doi: 10.1016/s0304-3835(00)00648-0. PMID: 11164186.


15: Beaulieu Leclerc V, Roy O, Santerre K, Proulx S. TGF-β1 promotes cell barrier function upon maturation of corneal endothelial cells. Sci Rep. 2018 Mar 13;8(1):4438. doi: 10.1038/s41598-018-22821-9. PMID: 29535350; PMCID: PMC5849742.


16: Zhou X, Zhu L, Bondy C, Wang J, Luo Q, Chen Y. AG1478 Elicits a Novel Anti- Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway. Int J Mol Sci. 2022 May 16;23(10):5557. doi: 10.3390/ijms23105557. PMID: 35628375; PMCID: PMC9145774.


17: Koumbadinga GA, Petitclerc E, Bouthillier J, Adam A, Marceau F. Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle. Eur J Pharmacol. 2009 Mar 15;606(1-3):233-9. doi: 10.1016/j.ejphar.2008.12.058. Epub 2009 Jan 21. PMID: 19374866.


18: Götte M, Sofeu Feugaing DD, Kresse H. Biglycan is internalized via a chlorpromazine-sensitive route. Cell Mol Biol Lett. 2004;9(3):475-81. PMID: 15332124.


19: Gerlach JP, van Buggenum JAG, Tanis SEJ, Hogeweg M, Heuts BMH, Muraro MJ, Elze L, Rivello F, Rakszewska A, van Oudenaarden A, Huck WTS, Stunnenberg HG, Mulder KW. Combined quantification of intracellular (phospho-)proteins and transcriptomics from fixed single cells. Sci Rep. 2019 Feb 6;9(1):1469. doi: 10.1038/s41598-018-37977-7. PMID: 30728416; PMCID: PMC6365588.


20: Feng PH, Hsiung TC, Kuo HP, Huang CD. Cross-talk between bradykinin and epidermal growth factor in regulating IL-6 production in human airway smooth muscle cells. Chang Gung Med J. 2010 Jan-Feb;33(1):92-9. PMID: 20184800.